Spiropiperidine compounds as ORL-1 receptor antagonists

Details for Australian Patent Application No. 2010319581 (hide)

Owner Eli Lilly and Company

Inventors Benito Collado, Ana Belen; Diaz Buezo, Nuria; Jimenez-Aguado, Alma Maria; Lafuente Blanco, Celia; Martinez-Grau, Maria Angeles; Pedregal-Tercero, Concepcion; Toledo Escribano, Miguel Angel

Agent Spruson & Ferguson

Pub. Number AU-A-2010319581

PCT Pub. Number WO2011/060035

Priority 61/298,629 27.01.10 US; 09382246.8 16.11.09 EP

Filing date 10 November 2010

Wipo publication date 19 May 2011

International Classifications

C07D 495/20 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/444 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

7 June 2012 PCT application entered the National Phase

  PCT publication WO2011/060035 Priority application(s): WO2011/060035

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010319593-Surface treatment composition, process for producing the same, and surfacetreated article

2010319559-Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to RGD binding sites